VERTEX PHARMACEUTICALS INC / MA — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+13.8% +$3.11B
$25.64B
Current Assets↑+16.7% +$1.60B
$11.20B
Cash & Equivalents↑+11.3% +$515M
$5.08B
ST Investments↓-1.5% -$23M
$1.52B
Receivables↑+27.6% +$443M
$2.05B
Inventory↑+39.9% +$481M
$1.69B
Net PPE
—
Goodwill↑+0.0% +$0
$1.09B
Intangibles↓-48.6% -$402M
$424M
Total Liabilities↑+13.9% +$854M
$6.98B
Current Liabilities↑+8.3% +$297M
$3.86B
Account Payables↑+11.8% +$49M
$462M
Long-Term Debt
—
Stockholders Equity↑+13.7% +$2.26B
$18.67B
Retained Earnings↑+41.2% +$3.95B
$13.56B
Operating Lease ROU Asset↑+15.2% +$206M
$1.56B
Operating Lease Liability↑+17.9% +$292M
$1.92B
Finance Lease ROU Asset↑+40.8% +$24M
$82M
Gross PP&E
—
Accumulated Depreciation
—
Inventory Raw Materials↑+3.1% +$8M
$260M
Inventory WIP↑+55.7% +$428M
$1.20B
Inventory Finished Goods↑+24.6% +$46M
$230M
Total Debt Carrying Amount
—
Contract Liability↓-16.9% -$35M
$172M